Virtual Screening, Identification and In Vitro Testing of Novel Inhibitors of O-Acetyl-L-Serine Sulfhydrylase of Entamoeba histolytica by Nagpal, Isha et al.
Virtual Screening, Identification and In Vitro Testing of
Novel Inhibitors of O-Acetyl-L-Serine Sulfhydrylase of
Entamoeba histolytica
Isha Nagpal
1, Isha Raj
1, Naidu Subbarao
2*, Samudrala Gourinath
1*
1School of Life Sciences, Jawaharlal Nehru University, New Delhi, India, 2School of Computational and Integrative Sciences, Jawaharlal Nehru University, New Delhi, India
Abstract
The explosive epidemicity of amoebiasis caused by the facultative gastrointestinal protozoan parasite Entamoeba histolytica
is a major public health problem in developing countries. Multidrug resistance and side effects of various available
antiamoebic drugs necessitate the design of novel antiamobeic agents. The cysteine biosynthetic pathway is the critical
target for drug design due to its significance in the growth, survival and other cellular activities of E. histolytica. Here, we
have screened 0.15 million natural compounds from the ZINC database against the active site of the EhOASS enzyme (PDB
ID. 3BM5, 2PQM), whose structure we previously determined to 2.4 A ˚ and 1.86 A ˚ resolution. For this purpose, the
incremental construction algorithm of GLIDE and the genetic algorithm of GOLD were used. We analyzed docking results for
top ranking compounds using a consensus scoring function of X-Score to calculate the binding affinity and using ligplot to
measure protein-ligand interactions. Fifteen compounds that possess good inhibitory activity against EhOASS active site
were identified that may act as potential high affinity inhibitors. In vitro screening of a few commercially available
compounds established their biological activity. The first ranked compound ZINC08931589 had a binding affinity of
,8.05 mM and inhibited about 73% activity at 0.1 mM concentration, indicating good correlation between in silico
prediction and in vitro inhibition studies. This compound is thus a good starting point for further development of strong
inhibitors.
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Introduction
Entamoeba histolytica, an anaerobic protozoan parasite, causes
amoebic colitis (also called amoebic dysentery) and amoebic
abscesses, and infects the liver, kidney and brain. [1]. These
infections are the third leading cause of death among the parasitic
diseases, surpassing malaria and schistosomiasis [2].
According to WHO, an estimated population of more than 280
million people are infected by E. histolytica, causing 2.5 million
deaths annually [3]. Several anti-amoebic drugs are currently
available, of which the most common ones are derivatives of 5-
nitromidazole including metronidazole and tinidazole. Some non-
imidazoles drugs such as nitazoxanide, paramomycin and
niridazole have also been found to be effective against E. histolytica.
However, these anti-amoebic drugs are less effective against the
cyst of E histolytica than the trophozoite. They also show various
adverse side effects, with nausea, vomiting, diarrhoea, and
hypersensitivity amongst the most common symptoms [4].
Neurological side effects of these drugs include dizziness, vertigo,
and encephalopathy. Metronidazole can also cross the placental
barriers, thus limiting its use. Moreover, cases of drug resistance in
E histolytica against 5-nitroimidazole derivatives have been
indicated by decreased uptake of metronidazole, and alteration
of the pyruvate-oxidizing metabolic pathway [5]. Thus, there is a
serious need for a new class of drugs that is more effective and that
produces fewer or no side effects.
Being parasitic, E histolytica exhibits a complex life cycle which
features an antigenically diverse stage (a typical characteristic of
protozoan parasites) in order to evade the host’s immune system
[1]. Other key factors that enhance the virulence of E histolytica,
include complement resistance, ROS and NOS scavenging
potential, and oxygen reduction capability. Oxygen is toxic for
the anaerobic protozoans, which damages parasite, and it also
destroys oxygen sensitive metabolic enzymes such as pyruvate
ferrodoxin oxidoreductase (PFOR), a key enzyme in the anaerobic
glycoltic pathway [6]. Cysteine plays a pivotal role in detoxifying
the effect of ROS and oxygen and it is crucial for survival of the
organism. Cysteine is also important for attachment and growth of
trophozites of E. histolytica. [7]. The major route of cysteine
biosynthesis in this organism is the condensation of O-Acetyserine
with the sulphide by the de novo cysteine biosynthetic pathway
involving two key enzymes: O-Acetyl-L-Serine Sulfhydrylase
(EhOASS) and Serine acetyl transferase (EhSAT), which can act
as promising targets for inhibiting the growth of E.histolytica. Both
enzymes are crucial for the cysteine biosynthetic pathway and
their structures have been determined in our laboratory [8,9]. The
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E.histolytica suggest them to be the best targets for designing
antiamoebic drugs.
Here we report the in silico screening of natural compounds and
preliminary biochemical investigations of inhibitor screening
against EhOASS. Two of the four commercially available
compounds showed micromolar binding affinity and one molecule
inhibits about 73% of EhOASS activity at 100 mM concentration.
Drug Target Protein: O-acetylserine Sulfhydrylase of
Entamoeba histolytica
The EhOASS polypeptide folds into two subunits. Each subunit
comprises an a/b domain, and each domain includes a relatively
small mobile N-terminal domain (residues 57–164) and a large rigid
C-terminal domain (residues 1–56 & 165–336). The active site is
located in the middle of these two domains and the cofactor PLP
(Pyridoxal59phosphate) is covalently linked to Lys-58, which is
conserved in all OASS structures and is also positioned in between
thesetwo domains.OtherhighlyconservedresiduessuchasGly236,
Ser280 and Pro307 interact with the aromatic ring of PLP [10].
Cysteine Biosynthetic Pathway
OASS catalyses the final step of cysteine biosynthesis, which is
the PLP (Pyridoxal 59phosphate) dependent conversion of O-
Acetyl serine into cysteine. O-Acetyl serine (OAS), generated from
serine and acetyl-CoA by SAT, reacts with the sulphide to produce
L-Cysteine. OASS catalyses this reaction by transferring sulphide
group to O-Acetyl serine (OAS) to form Cysteine [5].
The two key enzymes (i.e. OASS and SAT) of the cysteine
biosynthetic pathway are regulated through feedback inhibition of
SAT by cysteine as shown in Figure 1. Also, the C-terminal end of
SATcombineswithandblockstheactivesiteofOASSuponforming
thecysteinesynthasecomplex.TheC-terminalendofOASSfromE.
histolytica, however, is unique since it has small side chains
unfavourable for making strong interactions with OASS [8]. Since
there is a need to design novel inhibitors to target the active site of
EhOASS, which is a major regulator in the cysteine biosynthetic
pathwayofE. histolytica,We have used an insilicoapproach,and have
screened a large library of natural molecules against this target
enzyme. The screening of the library was performed using the
GLIDE GScore program in the Schrodinger software package
(Glide, v8.0, 2008) [11]. From our findings, we selected the best
ranking lead compounds and cross validated them with GOLD[12],
Finallypostdockinganalysiswasperformed using Xscore[13] which
calculates the binding affinity (hydrogen and hydrophobic interac-
tions) between the docked inhibitors and target protein.
Materials and Methods
Protein and Grid Preparation
The crystal structure of O-acetyl serine sulfhydrylase in complex
with cysteine determined by our group to a resolution of 2.4 A ˚
(PDB-ID 3BM5) was retrieved from the Protein Data Bank [9].
We also used the native structure determined at 1.86 A ˚ (PDB-ID
2PQM) as a reference. EhOASS has two subunits, an N and a C-
terminal domain. PLP, which is crosslinked to Lys 58 is located in
the middle of these two domains, forming the centre of the active
site. Protein is prepared using the Schrodinger protein preparation
wizard by removal of water and sulphate molecules, and addition
of hydrogen atoms, followed by minimization and optimization
using OPLS2005 force field in the premin option of Schrodinger
Glide. The shape and properties of the receptor are represented on
a grid by several different sets of fields that provide progressively
more accurate scoring of the ligand poses. We have generated the
grid that covers all the catalytic residues with PLP-Lys-58 in the
cavity.
The list of active site residues that are selected for grid
generation in the protein are V57,S84,T85, S86, G87, N88, T89,
G90, M112, S113, R116, Q159, F160, G192, T193, H232,
G233,I234,Q235, G236, I237, G238, A239, F241,Y313, T316,
and PLP-LYS-58 (Figure 2).
Ligand Library Preparation
The ligand library including 0.15 million natural compounds
was extracted from the ZINC database (http://zinc.docking.org/).
These molecules were then prepared in Schrodinger ligprep
wizard using the Lipinski filter. The shortlisted ligands were
subjected to further predocking preparations where hydrogens
were added followed by minimization and optimization in
OPLS_2005 force field. Finally, 10 conformations for each ligand
were generated, and ready for docking.
Docking of molecules to EhOASS structure using GLIDE
and Cross validation using GOLD
After preparing the ligand library and protein, and defining the
grid corresponding to the active site of the protein, docking
procedures were carried out. Our chosen software GLIDE uses
Systematic and Simulation method for searching the poses and
ligand flexibility. In a systematic method, it uses incremental
construction for searching, and its output GScore is an empirical
scoring function which is a combination of various parameters
[11] The GScore is calculated in Kcal/mol as:
G{ {Score~H bondz zLipoz zMetalz zSitez z0:130 Coul
z z0:065 vdW{ {BuryP{ {RotB
Where: Hbond=Hydrogen bonds, Lipo=hydrophobic interac-
tions, Metal=metal-binding term, Site=polar interactions in the
binding site, vdW=Vander-Waals forces, Coul=columbic forces,
Bury P=penalty for buried polar group, RotB=freezing rotable
bonds.
Library of Natural ligands were subjected to glide docking.
Since each ligand has 10 stereoisomers or conformations, each
Figure 1. Regulation of cysteine biosynthetic pathway through feedback inhibition of SAT by cysteine.
doi:10.1371/journal.pone.0030305.g001
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virtual screening (HTVS) module of GLIDE, from which the top
10% were subjected to the standard precision (SP) module. The
top 1,000 outcomes from SP were subjected to the extra precision
(XP) module for detailed docking. Finally, we selected the top 10
ranked ligands according to GLIDE and docked them again using
GOLD docking software to obtain consistent and improved
results. GOLD v4.0 [12] is an automated ligand-docking program
that uses a genetic algorithm to explore the full range of ligand
conformational flexibility, namely full acyclic ligand flexibility and
partial cyclic ligand flexibility, with partial flexibility of the protein
in the neighbourhood of the protein active site, and satisfies the
fundamental requirement that the binding of ligand must displace
loosely bound water. In GOLD docking, fifty independent docking
runs were performed for each molecule with default parameters.
Post Docking Analysis
A molecule was ranked relatively high if it scores well with these
two different methods (or scoring functions). These methods have
different search algorithms and scoring functions. Hence, it was
not possible to compare the fitness scores of GOLD and GLIDE
directly. For comparison and validation of docking result we used
X-Score v1.2.1, [13] a consensus scoring function. X-Score
calculates the negative logarithm of the dissociation constant of
the ligand to the protein, 2log Kd, as the average of three scoring
functions (HPScore, HMScore and HSScore), and predicts the
binding energy (Kcal/mol) of the ligand. X-Score was reported to
have an accuracy of 62.2 Kcal/mol relative to the actual binding
energies. For analysing the interactions of docked protein-ligand
complexes, the Ligplot programme [14] was used to check the
hydrogen bond and hydrophobic interactions between receptor
and ligand atoms within a range of 5 A ˚. Also PyMOL (V-1.3) [15]
and Chimera (V-1.4.1) [16] were used to visualize the interactions
and to prepare figures for top ranked molecules (Figure 3 & 4).
Validation through biochemical assays: inhibition and
binding studies
We were able to procure four of the shortlisted natural
inhibitor compounds. They were tested for their effect on enzyme
activity and interaction with the active site [8]. The enzyme
EhOASS was expressed and purified as described previously [10].
O-Acetyl-L-serine, DTNB, TCEP and HEPES were purchased
from Sigma. The sulfhydrylase activity was monitored using 5-
thio (2-nitrobenzoate) (TNB) as an alternative substrate. The
disappearance of TNB was monitored continuously at 412 nm
using the UV-visible spectrophotometer Ultrospec 21000pro.
The Km of EhOASS for its substrate OAS is 0.5 mM; hence an
activity check was carried out with 100 mM inhibitor in the
presence of 0.5 mM OAS to analyse the non-competitive effect
and also at 100 mM OAS to analyse the effect of inhibitor at
competitive levels of substrate. The non-competitive assay
contained the following in final concentrations: 100 mM HEPES,
pH 7.0, 0.5 mM OAS, 0.05 mM TNB and 25 mg of EhOASS.
The competitive assay contained 100 mM OAS instead of
0.5 mM OAS. Decrease in enzyme activity was monitored over
a fixed interval of time in the presence of 100 mMi n h i b i t o r .T h e
absorbance pattern of the standard reaction was compared with
those with the inhibitor, and percentage decrease in activity was
calculated using the following equation: 100-[(decrease in
absorbance for reactions with inhibitors/decrease in absorbance
for standard reaction) 6100].
The inhibitors that showed a reasonable decrease in activity
were studied further, to determine binding affinity. The fluorophor
PLP in the active site of OASS absorbs at 412 nm and emits at
510 nm. Titration of EhOASS with the active site-binding
inhibitors leads to an increase in emission at 510 nm Fluorescence
measurements were carried out using a Cary400 Scan fluorospec-
trophotometer (Varian Inc.). Emission spectra were recorded for a
solution containing 250 mg/ml EhOASS and 100 mM HEPES
Figure 2. Active site of EhOASS with reaction centre PLP (shown in blue) located at the middle of N and C terminal domain. A)
EhOASS (in ribbon) and reaction centre PLP (in sticks). B) EhOASS with electrostatic surface view and reaction centre PLP deep-seated (in sticks) is in
binding pocket.
doi:10.1371/journal.pone.0030305.g002
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Fluorescence peak was measured in absence of the inhibitor (F).
Difference in fluorescence arising due to addition of inhibitor, DF,
was also measured and corrected for dilution. The plot of inhibitor
concentration and DF/F follows a typical hyperbolic Michaelis-
Menten-like curve. Kd was determined by plotting 1/(DF/F)
versus 1/inhibitor concentration, as like a Lineweaver-Burk plot
(Figure 5A,B).
Figure 3. Post-docking interactions between active site residues of protein with ligand (ZINC08931589). (A)The protein is depicted in
surface view and ligand ZINC08931589 as stick in the binding pocket. (B) Schematic drawing of types of interactions of the ligands generated using
Ligplot.
doi:10.1371/journal.pone.0030305.g003
Figure 4. Post-docking interactions between active site residues of protein with ligand (ZINC03984585). (A) The protein is depicted in
surface view and ligand ZINC03984585 as stick in the binding pocket. (B) Schematic drawing of types of interactions of the ligands generated using
Ligplot.
doi:10.1371/journal.pone.0030305.g004
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O-Acetyl Serine Sulfhydrylase (OASS) is a promising and
established drug target in Entamoeba histolytica. This organism
causes amoebiasis for which there are few and poorly effective
drugs. It has PLP (pyridoxal phosphate) as a cofactor and plays a
crucial role in the cysteine biosynthetic pathway. Using the
GLIDE and GOLD docking programs, approximately 0.15
million natural compounds were screened from the ZINC
database against OASS to identify potential inhibitor molecule,
as explained in the Methods section.
The top ten ranking natural compounds based on GLIDE
scores are listed in Table 1. The GLIDE scores and Xscores of
these compounds have ranges of 213.01 to 210.91 Kcal/mol and
29.07 to 27.01 Kcal/mol, respectively. The top ranking
molecule (ZINC08931589, 4-hydroxy-2-[2-s(1H-indol-3-yl)-2-
oxoethyl]sulfanyl-1H-pyrimidin-6-one) has a Glide score of
213.01 Kcal/mol and Xscore of 27.76 Kcal/mol with 8
hydrogen bonds and 4 hydrophobic contacts (Table 1 & 2).
Conserved residues involved in hydrogen bonding interaction
include T85, S86, Q159, G87, R116, and G236. (except
ZINC04349228).
Figure 5. The plot between DF/F vs. inhibitor concentration follows a typical hyperbolic similar to Michaelis-Menton curve, the plot
between 1/DF/F vs. inhibitor concentration (the reciprocal plot) follows that of a Lineweaver-Burk plot, the Kd values of inhibitor A)
ZINC08931589 and B) ZINC03984585 were determined from these plots.
doi:10.1371/journal.pone.0030305.g005
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according to GLIDE are also predicted to bind strongly according
to GOLD. For each compound docked using the GLIDE and
GOLD programs, the Xscore (consensus scoring function)
program was used to calculate binding energies and listed in
Table 1 along with IUPAC name of the compounds, their
respective ZINC ID’s and interacting residues (hydrogen bonding
and hydrophobic contacts). Interactions (hydrogen and hydropho-
bic) for the top ten best ranking ligands based on glide score and
ligplot are listed in Table 2. The two ligands are shown in the
binding site of EhOASS and LIGPLOT diagrams are drawn
showing hydrogen bonding and hydrophobic contacts between the
docked poses of protein and ligands. (Figure 3 &4).
The ligand, ZINC08931589 is a ring structure having a
molecular weight of 301. 327 amu and a logP value of 2.81. It
showed the highest Glide score, 213.01 Kcal/mol, and Gold
score, 56.6. X-score was also reasonably good (27.7 Kcal/mol) for
this compound. In the docked model, there are 8 hydrogen bond
interactions and 4 hydrophobic interactions between the ligand
and the protein (Figure 3). The zeta nitrogen of the basic polar
amino acid Lys-58 forms a hydrogen bond with the atom S1 of the
ligand. Similarly, atoms NH1 and NH2 of the basic polar amino
acid Arg116 forms hydrogen bonds with the atom O2 of this
ligand. Meanwhile the atom O2 at c-1 position, makes hydrogen
bonds with the atom O1 of the ligand. All the hydrogen bonds
between this ligand and the protein are made with the active site of
Table 2. Calculated Hydrogen and Hydrophobic interactions for the top ten best ranking ligands based on Glide score and ligplot.
S.no: ZINC ID Hydrogen bond (#3.6 A ˚) Hydrophobic Interactions
1 ZINC08931589 T85, S86, Q159, PLP342, N88, Y313, R116,G236 G87, M136, G236, K58
2 ZINC04349228 T85, G87, Q159(3), K58 PLP342,I237,G236,G192,H232,Q235,A239,M136, F241, S84, F160
3 ZINC12405024 T85,S86, Q159,G236, S113, N88, T89, K58, I237 R116, M112, Q235, A239, G238, G192, PLP342, G87
4 ZINC13409670 T85, S86(2), G236, S84(2), Q159, S113 I140, F160, M136, F241, Q235, I237, G87
5 ZINC04349223 T85, S86(2), G87, Q159(2), K58 S84, I140, A239, G238, G236, PLP342,M136, F160
6 ZINC03984585 G87, S86, T85, R116, Q159, Y313 M136, A239, F160, T193, G129, G236, Q235, F241
7 ZINC04349749 T85, Q159, K58 I140, F160, F241, M136, Q235, R116, G87
8 ZINC13409674 T85, G236, S84(2), Q159, S86, S113 I240, F160, F241, M36, Q235, R116, G87
9 ZINC03984470 T85,S86, G87, R116, Q159, Y313 A239, G192, F160, G236, T193, Q235.
10 ZINC08740334 T85,S86,G87,R116, Q159,G236(2), Y313 M136, F160, G87, F241, A239, Q235, I237, G238, M112
doi:10.1371/journal.pone.0030305.t002
Table 1. Top ranking ligands (Natural compounds from Zinc database) after virtual screening against EhOASS using GLIDE and
GOLD docking programs.
S.No Zinc-Id
Ligand Iupac Name (Molecular
structures can be seen in Figure S1)
GlideScore
(Kcal/mol)
Glide X-Score
(Kcal/mol) Gold Score
Gold
Xscore
1 ZINC08931589 4-hydroxy-2-[2-(1H-indol-3-yl)-2-oxoethyl]sulfanyl-
1H-pyrimidin-6-one.
213.01 27.76 56.6 27.57
2 ZINC04349228 2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy8[(2S,3R,4R,5S,6R)-3,4,5-
trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one.
212.64 28.5 45.71 28.64
3 ZINC12405024 (2R,3S,4R,5R)-2,3,5,6-tetrahydroxy-4-[(2S,3R,4S,5R,6R)-3,4,5-
trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexanoate.
212.1 27.01 46 26.79
4 ZINC13409670 3-((S)-3,4-Dihydroxy-1-methoxy-2-oxo-pentyl)-2,6,8,9-
tetrahydroxy-7-methyl-3,4-dihydro-2H-anthracen-1-one.
211.72 28.88 45.82 28.41
5 ZINC04349223 2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-8-[3,4,5-trihydroxy-6-
(hydroxymethyl)oxan-2-yl]oxychromen-4-one.
211.7 28.93 69.29 28.1
6 ZINC03984585 3-[3-acetyl-4-hydroxy-2-(4-methoxyphenyl)-5-oxo-2,5-
dihydro-1H-pyrrol-1-yl]propanoic acid.
211.49 27.79 59.52 27.78
7 ZINC04349749 5,7-dihydroxy-2-(4-hydroxyphenyl)-8-[(2S,3R,5S)-3,4,
5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]chromen-4-one
211.37 29.07 56.77 29.09
8 ZINC13409674 (3R)-3-[(1S,3S,4S)-3,4-dihydroxy-1-methoxy-2-oxopentyl]-8,9-
dihydroxy-7-methyl-3,4-dihydro-2H-anthracen-1-one.
211.3 28.89 39.92 28.52
9 ZINC03984470 6-[3-acetyl-2-(4-bromophenyl)-4-hydroxy-5-oxo-2,5-dihydro-1H-
pyrrol-1-yl]hexanoic acid.
211.02 28.02 59.79 28.09
10 ZINC08740334 (2S,3R,4S,5R,6R)-2-[(2R,3S,4R,5R)-6-(3,4-dimethylanilino)-4,5-
dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6(hydroxymethyl)
oxane-3,4,5-triol.
210.91 28.6 45.5 28.11
doi:10.1371/journal.pone.0030305.t001
Inhibitors for O-Acetyl-L-Serine Sulfhydrylase
PLoS ONE | www.plosone.org 6 February 2012 | Volume 7 | Issue 2 | e30305the protein, as described. PLP-Lys58 makes a 2.4 A ˚-long hydrogen
bond with the N3 atom of the ligand.
The ligand ZINC03984585 has a molecular weight of 360.386
amu, logP of 1.63 with a GLIDE score of 211.49 Kcal/mol and
GOLD score of 59.52 (Table 1). In our study, this 6
th ranked
compound forms 6 hydrogen bonds and 8 hydrophobic interac-
tions with the receptor (Table 2). Hydrogen bonds are formed by
Thr85, Ser86, Arg116 and Gln159, as is the case for
ZINC08931589. In addition, neutral nonpolar amino acids
Gly87, Gly192, Gln235, Gly236, and Ala239 are also involved
in some hydrophobic interactions. (Figure 4).
From the biochemical studies, the compound ranked first
showed about 73% decrease in activity, while the compound
ZINC03984585 ranked 6
th showed 21% decrease in activity at
Km level of substrate. At equal concentration of substrate and
inhibitor, the percent decrease in activity was found to be greater
(Table 3). There is thus a a good correlation between our
prediction and experimental results. The binding affinity for
compound ZINC08931589 is approximately 8 mM whereas that
for compound ZINC03984585 is 0.18 mM (Figure 5A,B). The
compound ZINC03984585 shows better binding affinity but less
inhibition. This difference is not an aberration as compounds
showing better Kd do not necessarily have a better efficacy [17].
Hence, though ZINC08931589 has a lower binding affinity, it has
a higher efficacy at inhibiting the enzyme.
Conclusion
There is an urgent need to design and develop novel
antiamobeic agents due to multidrug resistance and side effects
of various available antiamoebic drugs. The EhOASS enzyme of
the cysteine biosynthetic pathway is a potential drug target in
E.histolytica. We have identified few novel inhibitors by in silico
screening of a natural library of compounds from the ZINC
database using GLIDE and GOLD docking programs. Our
docking results for the top ten candidates, which are discussed in
the paper, are supported by post docking analysis and indicate
strong binding affinity for EhOASS. A few commercially available
compounds have been procured and in vitro testing has been
carried out for biological activity. Four of the six compounds have
shown biological activity when tested experimentally and the
results correlated well with in silico studies. The top ranking
compound inhibited the activity of the enzyme by almost 73% at
100 mM concentration. These results validate our docking studies.
These compounds may act as lead molecules for high affinity
inhibitory molecule development, which could be potential drug
molecules against E. histolytica.
Supporting Information
Figure S1 The molecular structure of top ranking
inhibitors (Natural compounds from zinc database)
after virtual screening against EhOASS using GLIDE
and GOLD docking programs as listed in Table 1.
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